The Riddle of Protein Diagnostics: Future Bleak or Bright?

被引:45
作者
Anderson, N. Leigh [1 ]
Ptolemy, Adam S. [2 ,3 ]
Rifai, Nader [3 ,4 ]
机构
[1] Plasma Proteome Inst, Washington, DC 20009 USA
[2] Brigham & Womens Hosp, Dept Lab Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[4] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA
关键词
VALIDATION;
D O I
10.1373/clinchem.2012.184705
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:194 / 197
页数:4
相关论文
共 5 条
[1]   Within Sight of a Rational Pipeline for Development of Protein Diagnostics [J].
Anderson, Leigh .
CLINICAL CHEMISTRY, 2012, 58 (01) :28-30
[2]   The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum [J].
Anderson, N. Leigh .
CLINICAL CHEMISTRY, 2010, 56 (02) :177-185
[3]  
Lee BG, 2008, ARTECH HSE MOB COMM, P1
[4]   What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema [J].
Ptolemy, Adam S. ;
Rifai, Nader .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2010, 70 :6-14
[5]   Protein biomarker discovery and validation: the long and uncertain path to clinical utility [J].
Rifai, Nader ;
Gillette, Michael A. ;
Carr, Steven A. .
NATURE BIOTECHNOLOGY, 2006, 24 (08) :971-983